Recent advances in the biochemistry and clinical relevance of the isoprostane pathway

Lipids

Volumn 40, Issue 10, 2005, Pages 987-994

  Musiek, Erik S ^a   Yin, Huiyong ^a   Milne, Ginger L ^a   Morrow, Jason D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDS; BIOCHEMISTRY; BIOMARKERS; DISEASES; OXIDATION; PEROXIDES;

LIPID PEROXIDATION; PEROXIDATION PRODUCTS; RACEMIC PROSTAGLANDINS; REGIOISOMERIC DISTRIBUTION;

LIPIDS;

1,3 DIOXOLANE DERIVATIVE; ARACHIDONIC ACID; BIOLOGICAL MARKER; CYCLOPENTENONE DERIVATIVE; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOLIPASE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN;

ALZHEIMER DISEASE; ATHEROSCLEROSIS; BIOCHEMISTRY; CYCLIZATION; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HEART MUSCLE ISCHEMIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LIPID PEROXIDATION; MASS SPECTROMETRY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; STEREOCHEMISTRY; ANIMAL; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; ISOMERISM; MASS FRAGMENTOGRAPHY; METABOLISM; PHYSIOLOGY; RISK FACTOR;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; F2-ISOPROSTANES; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; ISOMERISM; ISOPROSTANES; LIPID PEROXIDATION; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PROSTAGLANDINS; RISK FACTORS;

EID: 33644874681     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-005-1460-7     Document Type: Review

References (71)

1. 2-like Compounds Are Produced in vivo in Humans by a Non-cyclooxygenase, Free Radical-Catalyzed Mechanism, Proc. Natl. Acad. Sci. USA 87, 9383-9387.
2. Morrow, J.D., Harris, T.M., and Roberts, L.J., II (1990) Noncyclooxygenase Oxidative Formation of a Series of Novel Prostaglandins: Analytical Ramifications for Measurement of Eicosanoids, Anal. Biochem. 184, 1-10.
3. 2-Isoprostanes in Biological Fluids and Tissues as Measure of Oxidant Stress, Methods Enzymol. 300, 3-12.
4. Taber, D.F., Morrow, J.D., and Roberts, L.J., II (1997) A Nomenclature System for the Isoprostanes, Prostaglandins 53, 63-67.
5. 2-isoprostanes) Are Formed in situ on Phospholipids, Proc. Natl. Acad. Sci. USA 89, 10721-10725.
6. Chen, Y., Morrow, J.D., and Roberts, L.J., II (1999) Formation of Reactive Cyclopentenone Compounds in vivo as Products of the Isoprostane Pathway, J. Biol. Chem. 274, 10863-10868.
7. Fam, S.S., and Morrow, J.D. (2003) The Isoprostanes: Unique Products of Arachidonic Acid Oxidation-A Review, Curr. Med. Chem. 10, 1723-1740.
8. Lawson, J.A., Rokach, J., and FitzGerald, G.A. (1999) Isoprostanes: Formation, Analysis and Use as Indices of Lipid Peroxidation in vivo, J. Biol. Chem. 274, 24441-24444.
9. Rokach, J., Khanapure, S.P., Hwang, S.W., Adiyaman, M., Lawson, J.A., and FitzGerald, G.A. (1997) Nomenclature of Isoprostanes: A Proposal, Prostaglandins 54, 853-873.
10. Morrow, J.D., and Roberts, L.J., II (2001) Lipid-Derived Autocoids: Eicosanoids and Platelet Activating Factor, in Goodman and Gilman's The Pharmcological Basis of Therapeutics (Hardman, J.G., and Limbird, L.E., eds.), pp. 669-687, McGraw-Hill, New York.
11. Roberts, L.J., II, and Morrow, J.D. (2002) Products of the Isoprostane Pathway: Unique Bioactive Compounds and Markers of Lipid Peroxidation, Cell. Mol. Life Sci. 59, 808-820.
12. Rokach, J., Khanapure, S.P., Hwang, S.W., Adiyaman, M., Lawson, J.A., and FitzGerald, G.A. (1997) The Isoprostanes: A Perspective, Prostaglandins 54, 823-851.
13. 2, a Chemical Analog of the Biosynthetic Pathway, Tetrahedron Lett. 35, 539-542.
14. Yin, H., Havrilla, C.M., Gao, L., Morrow, J.D., and Porter, N.A. (2003) Mechanisms for the Formation of Isoprostane Endoperoxides from Arachidonic Acid. "Dioxetane" Intermediate Versus β-Fragmentation of Peroxyl Radicals, J. Biol. Chem. 278, 16720-16725.
15. 2-Isoprostane Regioisomers Formed in vivo in the Rat, Free Radic. Biol. Med. 23, 943-954.
16. Yin, H., Morrow, J.D., and Porter, N.A. (2004) Identification of a Novel Class of Endoperoxides from Arachidonate Autoxidation, J. Biol. Chem. 279, 3766-3776.
17. Yin, H., Havrilla, C.M., Morrow, J.D., and Porter, N.A. (2002) Formation of Isoprostane Bicyclic Endoperoxides from the Autoxidation of Cholesteryl Arachidonate, J. Am. Chem. Soc. 124, 7745-7754.
18. Yin, H., Porter, N.A., and Morrow, J.D. (2005) Separation and Identification of F(2)-Isoprostane Regioisomers and Diastereomers by Novel Liquid Chromatographic/Mass Spectrometric Methods, J. Chromatogr. B, epub ahead of print.
19. Morrow, J.D., Minton, T.A., Mukundan, C.R., Campbell, M.D., Zackert, W.E., Daniel, V.C., Badr, K.F., Blair, I.A., and Roberts, L.J., II (1994) Free Radical-Induced Generation of Isoprostanes in vivo. Evidence for the Formation of D-Ring and E-Ring Isoprostanes, J. Biol. Chem. 269, 4317-4326.
20. Montine, T.J., Montine, K.S., Reich, E.E., Terry, E.S., Porter, N.A., and Morrow, J.D. (2003) Antioxidants Significantly Affect the Formation of Different Classes of Isoprostanes and Neuroprostanes in Rat Cerebral Synaptosomes, Biochem. Pharmacol. 65, 611-617.
21. Montine, T.J., Neely, M.D., Quinn, J.F., Beal, M.F., Markesbery, W.R., Roberts, L.J., and Morrow, J.D. (2002) Lipid Peroxidation in Aging Brain and Alzheimer's Disease, Free Radic. Biol. Med. 33, 620-626.
22. Reich, E.E., Markesbery, W.R., Roberts, L.J., II, Swift, L.L., Morrow, J.D., and Montine, T.J. (2001) Brain Regional Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer's Disease, Am. J. Pathol. 158, 293-297.
23. Reich, E.E., Markesbery, W.R., Roberts, L.J., II, Swift, L.L., Morrow, J.D., and Montine, T.J. (2001) Quantification of F-Ring and D-/E-Ring Isoprostanes and Neuroprostanes in Alzheimer's Disease, Adv. Exp. Med. Biol. 500, 253-256.
24. Musiek, E.S., Milne, G.L., McLaughlin, B., and Morrow, J.D. (2005) Cyclopentenone Eicosanoids as Mediators of Neurodegeneration: A Pathogenic Mechanism of Oxidative Stress-Mediated and Cyclooxygenase-Mediated Neurotoxicity, Brain Pathol. 15, 149-158.
25. 2) Isoprostanes-Unique, Highly Reactive Products of Arachidonate Peroxidation, Antioxid. Redox Signal. 7, 210-220.
26. 2t-Isoprostane, Is Efficiently Metabolized by HepG2 Cells via Conjugation with Glutathione, Chem. Res. Toxicol. 17, 17-25.
27. 2), Is Efficiently Conjugated with Glutathione by Human and Rat Glutathione Transferase A4-4, Chem. Res. Toxicol. 15, 1114-1118.
28. 2t-Isoprostane in vivo, J. Biol. Chem. 280, 25178-25184.
29. Musiek, E.S., Milne, G.L., Breeding, R.L., Morrow, J.D., and McLaughlin, B. (2005) Cyclopentenone Isoprostanes, Novel Bioactive Products of Lipid Oxidation, Enhance Neurodegeneration, J. Neurochem., in press.
30. 2 Isoprostane, J. Org. Chem. 67, 4346-4351.
31. 2 Isoprostane, J. Org. Chem. 68, 6005-6010.
32. Xie, C., Lovell, M.A., Xiong, S., Kindy, M.S., Guo, J., Xie, J., Amaranth, V., Montine, T.J., and Markesbery, W.R. (2001) Expression of Glutathione-S-Transferase Isozyme in the SY5Y Neuroblastoma Cell Line Increases Resistance to Oxidative Stress, Free Radic. Biol. Med. 31, 73-81.
33. Zimniak, L., Awasthi, S., Srivastava, S.K., and Zimniak, P. (1997) Increased Resistance to Oxidative Stress in Transfected Cultured Cells Overexpressing Glutathione S-Transferase mGSTA4-4, Toxicol. Appl. Pharmacol. 143, 221-229.
34. Beal, M.F. (1995) Aging, Energy, and Oxidative Stress in Neurodegenerative Diseases, Ann. Neurol. 38, 357-366.
35. Keller, J.N., and Mattson, M.P. (1998) Roles of Lipid Peroxidation in Modulation of Cellular Signaling Pathways, Cell Dysfunction, and Death in the Nervous System, Rev. Neurosci. 9, 105-116.
36. Musiek, E.S., Gao, L., Milne, G.L., Han, W., Everhart, M.B., Wang, D., Backlund, M.G., Dubois, R.N., Zanoni, G., Vidari, G., Blackwell, T.S., and Morrow, J.D. (2005) Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages, J. Biol. Chem. doi:10.1074jbc.M504785200.
37. 2α in Different Rheumatic Diseases, Ann. Rheum. Dis. 60, 627-631.
38. 2 via the Isoprostane Pathway: A Mechanism for the Generation of Bioactive Prostaglandins Independent of Cyclooxygenase, J. Biol. Chem. 278, 28479-28489.
39. 2 Synthesis in Healthy Humans and Those with Lung Cancer, Anal Biochem. 334, 266-275.
40. 2-Isoprostanes as Markers of Oxidant Stress: An Overview, in Current Protocols in Toxicology (Costa, L.G., Hodgson, E., Lawrence, D. and Reed, D.J., eds.), Supp. 24, 17.5-17.6, John Wiley & Sons, New York
41. 2α-I: An Index of Lipid Peroxidation in Humans, Proc. Natl. Acad. Sci. USA 95, 3449-3454.
42. Morrow, J.D., and Roberts, J., II (1997) The Isoprostanes: Unique Bioactive Products of Lipid Peroxidation, Prog. Lipid Res. 36, 1-21.
43. 2α in Humans, J. Biol. Chem. 271, 20617-20620.
44. 2α) by a Stable Isotope Dilution Mass Spectrometric Assay, Anal. Biochem. 269, 326-331.
45. 2α) by a Stable Isotope Dilution Mass Spectrometric Assay, Clin. Chim. Acta 314, 93-99.
46. 4 Poisoning? Free Radic. Biol. Med. 38, 698-710.
47. 4 Poisoning, Free Radic. Biol. Med. 38, 711-718.
48. 2t-isoprostane, Ann. Epidemiol. 14, 793-797.
49. 2-Isoprostanes in Human Urine, Proc. Natl. Acad. Sci. USA 96, 13381-13386.
50. Bohnstedt, K.C., Karlberg, B., Wahlund, L.O., Jonhagen, M.E., Basun, H., and Schmidt, S. (2003) Determination of Isoprostanes in Urine Samples from Alzheimer Patients Using Porous Graphitic Carbon Liquid Chromatography-Tandem Mass Spectrometry, J. Chromatogr. B 796, 11-19.
51. 2α in Human Plasma and Urine by Liquid Chromatography-Electrospray Ionization Mass Spectrometry, J. Chromatogr. B 746, 17-24.
52. 2α in Human Urine Using Liquid Chromatography-Tandem Mass Spectrometry, Free Radic. Biol. Med. 34, 409-418.
53. Morrow, J.D. (2005) Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans, Arterioscler. Thromb. Vasc. Biol. 25, 279-286.
54. Praticò, D., Tangirala, R.K., Rader, D.J., Rokach, J., and FitzGerald, G.A. (1998) Vitamin E Suppresses Isoprostane Generation in vivo and Reduces Atherosclerosis in ApoE-Deficient Mice, Nat. Med. 4, 1189-1192.
55. Praticò, D., Uryu, K., Leight, S., Trojanoswki, J.Q., and Lee, V.M. (2001) Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis, J. Neurosci. 21, 4183-4187.
56. Kaikkonen, J., Porkkala-Sarataho, E., Morrow, J.D., Roberts, L.J., II, Nyyssonen, K., Salonen, R., Tuomainen, T.P., Ristonmaa, U., Poulsen, H.E., and Salonen, J.T. (2001) Supplementation with Vitamin E but Not with Vitamin C Lowers Lipid Peroxidation in vivo in Mildly Hypercholesterolemic Men, Free Radic. Res. 35, 967-978.
57. Patrono, C., and FitzGerald, G.A. (1997) Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease, Arterioscler. Thromb. Vasc. Blol. 17, 2309-2315.
58. 2α and Platelet Activation in Diabetes Mellitus: Effects of Improved Metabolic Control and Vitamin E Supplementation, Circulation 99, 224-229.
59. Hansel, B., Giral, P., Nobecourt, E., Chantepie, S., Bruckert, E., Chapman, M.J., and Kontush, A. (2004) Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity, J. Clin. Endocrin. Metab. 89, 4963-4971.
60. Morrow, J.D. (2003) Is Oxidant Stress a Connection Between Obesity and Atherosclerosis? Arterioscler. Thromb. Vasc. Biol. 23, 368-370.
61. 2α Generation During Coronary Reperfusion. A Potential Quantitative Marker of Oxidant Stress in vivo, Circulation 95, 2492-2499.
62. 2-Isoprostanes in Alzheimer's Disease, J. Alzheimer's Dis. 6, 93-97.
63. 2-Isoprostanes, Are Present in Increased Amounts in Human Atherosclerotic Lesions, Arterioscler. Thromb. Vasc. Biol. 17, 3236-3241.
64. 2-isoprostanes) in Smokers. Smoking as a Cause of Oxidative Damage, N. Engl. J. Med. 332, 1198-1203.
65. 2α as a Risk Marker in Patients with Coronary Heart Disease: A Matched Case-Control Study, Circulation 109, 843-848.
66. 2-Isoprostanes and Coronary Artery Calcification: The CARDIA Study, Clin. Chem. 51, 125-131.
67. Vassalle, C., Petrozzi, L., Botto, N., Andreassi, M.G., and Zucchelli, G.C. (2004) Oxidative Stress and Its Association with Coronary Artery Disease and Different Atherogenic Risk Factors, J. Int. Med. 256, 308-315.
68. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. (1994) The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers, N. Engl. J. Med. 330, 1029-1035.
69. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (1999) Dietary Supplementation with n-3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the GISSI-Prevenzione Trial, Lancet 354, 447-455.
70. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P. (2000) Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients: The Heart Outcomes Prevention Evaluation Study Investigators, New Engl. J. Med. 342, 154-160.
71. Meagher, E.A., Barry, O.P., Lawson, J.A., Rokach, J., and FitzGerald, G.A. (2001) Effects of Vitamin E on Lipid Peroxidation in Healthy Persons, JAMA 285, 1178-1182.